Aayush Wellness Limited, an integrated healthcare and preventive wellness company, has announced the launch of Aayush Dia Shield Tablets, marking its strategic entry into India's diabetes and metabolic health sector. The announcement was made under Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, on May 08, 2026. The product is a science-backed dietary supplement designed to address the escalating metabolic health challenge in India, where over 230 million individuals are currently affected by diabetes or pre-diabetes.

Addressing a National Health Priority

India is currently grappling with a significant metabolic health burden, with over 100 million people living with diabetes and an additional 136 million classified as pre-diabetic. Notably, nearly 50% of cases remain undiagnosed, and the prevalence is rising sharply among working professionals aged 30–45. Aayush Dia Shield Tablets are formulated to provide a preventive and supportive solution for long-term blood sugar management, catering to an increasingly health-conscious population.

Science-Backed Botanical Formulation

Aayush Dia Shield Tablets feature a blend of time-tested herbal extracts specifically chosen for their metabolic benefits. The formulation draws on established botanical ingredients to support blood sugar management and overall metabolic wellness.

• Trigonella foenum-graecum (Fenugreek/Methi): Enhances insulin response and sugar control.
• Momordica charantia (Karela): Naturally supports lower blood sugar levels and bowel regularity.
• Gymnema sylvestre (Gurmar): Assists in reducing sugar absorption and cutting cravings.
• Cinnamon Bark Extract: Enhances digestion and improves glucose utilization.

Key Benefits of Aayush Dia Shield Tablets

The product is positioned as a comprehensive wellness supplement with multiple functional benefits:

• Metabolic Support: Promotes efficient glucose metabolism and energy utilization.
• Antioxidant Defense: Combats oxidative stress linked to lifestyle-related imbalances.
• Holistic Vitality: Supports digestive health, nutrient absorption, and overall daily wellness.
• Overall Wellness: A comprehensive supplement aimed at long-term metabolic and lifestyle health support.

Strategic Market Positioning

The launch positions Aayush Wellness within the high-growth ₹366.56 billion metabolic health market. As a nutraceutical product, Aayush Dia Shield Tablets are designed for modern lifestyles, offering a convenient daily format that fosters repeat-consumption behavior. Managing Director Naveena Kumar commented on the launch: "India's diabetes challenge represents both a major public health priority and a significant wellness opportunity. With Aayush Dia Shield Tablets, we are strengthening our preventive healthcare portfolio with a solution aligned to evolving consumer needs and our long-term growth strategy."

About Aayush Wellness Limited

Aayush Wellness Limited, established in 1984, is an ISO 9000 and ISO 22000 certified company and a pioneering name in health and wellness solutions. The company is dedicated to offering products that merge wellbeing with innovation and is committed to promoting healthier lifestyle choices through its diverse range of wellness products and services.

Aayush Wellness Limited has submitted its quarterly compliance certificate to BSE Limited and Metropolitan Stock Exchange of India Limited for the quarter ended March 31, 2026. The filing, dated April 13, 2026, fulfills the company's regulatory obligations under SEBI (Depositories and Participants) Regulations 2018.

Regulatory Compliance Filing

The certificate was issued in accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. Managing Director Naveenakumar Kunjaru signed the submission on behalf of Aayush Wellness Limited, confirming the company's compliance with mandatory reporting requirements.

Registrar Confirmation

Beetal Financial & Computer Services (P) Ltd., serving as the company's registrar and share transfer agent, provided the compliance certificate dated April 3, 2026. The SEBI-approved Category I registrar confirmed proper handling of securities dematerialization processes during the quarter.

The registrar's certificate confirms that:

• Securities received from depository participants for dematerialization were properly confirmed to depositories
• Security certificates received for dematerialization were mutilated and cancelled after due verification
• Depository names were substituted in the register of members as registered owners within the prescribed 15-day timeframe

Stock Exchange Notifications

The compliance certificate was submitted to multiple exchanges where Aayush Wellness Limited securities are listed:

Depository Communications

Copies of the compliance certificate were also forwarded to both major depositories in India - National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL), ensuring comprehensive regulatory compliance across all relevant market infrastructure institutions.

The submission represents routine quarterly compliance activity, demonstrating the company's adherence to securities market regulations and proper maintenance of shareholder records through its appointed registrar and transfer agent.